Back

Renin-angiotensin system inhibitors can be a first choice drug for hypertension in patients treated with vascular endothelial growth factor inhibitors

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Hypertension e-posters Renin-Angiotensin System ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Shohei Moriyama

Kyushu University Hospital, Fukuoka (Japan)

110 More presentations in this session

Presentation thumbnail
Exercise intensities modulate cognitive function in spontaneously hypertensive rats through oxidative mediated synaptic plasticity in hippocampus
Professor T. Lee (Tainan, TW)
Abstract Slides
Presentation thumbnail
Arterial stiffness and the risk of heart failure formation in rotational shift workers in the arctic
Doctor N. Shurkevich (Tyumen, RU)
Abstract Slides
Presentation thumbnail
Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Renal denervation in truly resistant hypertensive patients: six-year follow-up results of a single-center study
Doctor M. Ionov (Saint Petersburg, RU)
Abstract Slides

Access the full session

Session thumbnail
Hypertension e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Session
Arterial hypertension
thumbnail
Congress Session
Hypertension with cardiometabolic comorbidities: which drugs to select and which to avoid
thumbnail
Congress Presentation
RNA interference for treating hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources